Steve Schonfeld’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$692K Buy
+187,086
New +$984K ﹤0.01% 1808
2024
Q3
– Sell
-102,635
Closed -$512K – 2469
2024
Q2
$512K Buy
+102,635
New +$586K ﹤0.01% 1477
2023
Q2
– Sell
-11,200
Closed -$48.5K – 2549
2023
Q1
$48.5K Buy
+11,200
New +$51.3K ﹤0.01% 1772
2020
Q4
– Sell
-48,000
Closed -$408K – 1914
2020
Q3
$408K Sell
48,000
-24,100
-33% -$264K 0.01% 982
2020
Q2
$750K Buy
+72,100
New +$678K 0.02% 692
2019
Q2
– Sell
-67,000
Closed -$2.6M – 1278
2019
Q1
$2.6M Buy
67,000
+47,000
+235% +$1.91M 0.09% 281
2018
Q4
$841K Hold
20,000
– – 0.03% 520
2018
Q3
$1M Sell
20,000
-10,000
-33% -$451K 0.04% 430
2018
Q2
$1.15M Sell
30,000
-10,163
-25% -$437K 0.06% 371
2018
Q1
$1.61M Sell
40,163
-44,193
-52% -$1.86M 0.12% 237
2017
Q4
$2.96M Buy
+84,356
New +$2.46M 0.24% 125

Other funds holding WVE

Steve Schonfeld's WVE Position: Q3 2026 in Review

Steve Schonfeld opened a new position in Wave Life Sciences (WVE) in Q3 2026: 187,086 shares worth $692K. The stake represents ﹤0.01% of the portfolio and ranks #1808 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in WVE as recently as Q2 2024.

Steve Schonfeld first reported a position in WVE in Q4 2017 and has held it in 11 quarters since. The position peaked at $2.96M in Q4 2017. 211 funds tracked by Wall St. Rank hold WVE as of Q3 2026.

  • Steve Schonfeld held 187,086 shares of Wave Life Sciences worth $692K as of Q3 2026.
  • Wave Life Sciences was a new Steve Schonfeld position in Q3 2026.
  • Wave Life Sciences made up ﹤0.01% of Steve Schonfeld's portfolio in Q3 2026, its #1808 holding.
  • Steve Schonfeld first reported a position in Wave Life Sciences in Q4 2017 and has held it in 11 quarters since.
  • Steve Schonfeld's Wave Life Sciences position peaked at $2.96M in Q4 2017.
  • 211 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.